Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 8 call positions ($63.1m notional), 3 put positions ($46.5m notional) – listed below, not included above.
Holdings, Q1 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| AMARIN CORP PLC SPONS ADR NEW | $104.9m8.60% | Added +952.9k |
| UNITED THERAPEUTICS CORP DEL UTHR | $81.4m6.67% | Added +27.9k |
| ARK ETF TR ARKG | $71.6m5.87% | New |
| ALEXION PHARMACEUTICALS INC ALXN | $71.3m5.84% | Added +89.8k |
| HORIZON THERAPEUTICS PUB L HZNP | $64.0m5.24% | Added +164.5k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $50.3m4.12% | Added +1.6m |
| ASTRAZENECA PLC SPONSORED ADR | $49.3m4.04% | Added +139.9k |
| ASCENDIS PHARMA A/S SPONSORED ADR | $40.2m3.29% | Added +124.8k |
| DANAHER CORPORATION DHR | $40.0m3.28% | Added +51.2k |
| TG THERAPEUTICS INC TGTX | $36.8m3.01% | Reduced -101.3k |
| ACCELERON PHARMA INC XLRN | $32.8m2.69% | New |
| COMMUNITY HEALTH SYS INC NEW CYH | $32.5m2.66% | Added +2.4m |
| AMNEAL PHARMACEUTICALS INC AMRX | $32.0m2.62% | Added +3.6m |
| GLAXOSMITHKLINE PLC SPONSORED ADR | $31.1m2.54% | Reduced -94.4k |
| ENVISTA HOLDINGS CORPORATION NVST | $29.9m2.45% | Reduced -128.7k |
| AVANTOR INC AVTR | $27.7m2.27% | Added +38.3k |
| ORTHO CLINICAL DIAGNOSTICS H OCDX | $26.5m2.17% | New |
| FATE THERAPEUTICS INC FATE | $26.5m2.17% | Reduced -77.7k |
| MCKESSON CORP MCK | $24.0m1.97% | New |
| ELEVANCE HEALTH INC ELV | $22.9m1.88% | Reduced -1.9k |
| QIAGEN NV SHS NEW | $22.1m1.81% | Added +117.9k |
| CATALENT INC CTLT | $17.2m1.41% | Reduced -116.4k |
| BECTON DICKINSON & CO BDX | $16.6m1.36% | New |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $16.6m1.36% | Added +138.4k |
| HCA HEALTHCARE INC HCA | $16.1m1.32% | Added +68.7k |
| ZOGENIX INC ZGNX | $16.1m1.32% | Reduced -86.5k |
| DECIPHERA PHARMACEUTICALS IN DCPH | $15.5m1.27% | Added +99.5k |
| TARO PHARMACEUTICAL INDS LTD TARO | $12.1m0.99% | Added +12.1k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $11.4m0.94% | New |
| ACADIA PHARMACEUTICALS INC ACAD | $10.8m0.89% | New |
| HUMANA INC HUM | $10.4m0.86% | New |
| INTRA-CELLULAR THERAPIES INC ITCI | $10.2m0.84% | Reduced -55.6k |
| ARGENX SE ARGX | $9.9m0.81% | New |
| ARK ETF TR ARKK | $9.8m0.81% | New |
| MAGELLAN HEALTH INC MGLN | $9.8m0.80% | Unchanged |
| THE CIGNA GROUP CI | $9.7m0.79% | New |
| MANNKIND CORP MNKD | $8.5m0.70% | New |
| AFFIMED N V COM | $8.3m0.68% | Added +81.4k |
| DEXCOM INC DXCM | $6.7m0.55% | Added +16.3k |
| GUARDANT HEALTH INC GH | $6.1m0.50% | New |
| NOVAVAX INC NVAX | $6.1m0.50% | New |
| NATERA INC NTRA | $5.9m0.48% | New |
| CENTENE CORP DEL CNC | $5.8m0.48% | New |
| SURGALIGN HOLDINGS INC RTIX | $5.8m0.47% | New |
| KADMON HLDGS INC KDMN | $5.3m0.44% | Reduced -1.0m |
| SERES THERAPEUTICS INC COM | $4.4m0.36% | Reduced -118.8k |
| LUMINEX CORP DEL COM | $4.3m0.35% | New |
| IMMUNOVANT INC IMVT | $3.7m0.30% | New |
| FIVE PRIME THERAPEUTICS INC FPRX | $3.5m0.29% | Reduced -115.9k |
| ENSIGN GROUP INC ENSG | $2.7m0.22% | Reduced -179.6k |
| SURMODICS INC SRDX | $2.7m0.22% | Added +6.6k |
| ALPHA HEALTHCARE ACQUISTN CO CL A | $2.6m0.21% | New |
| LEXICON PHARMACEUTICALS INC LXRX | $2.4m0.20% | New |
| AGILENT TECHNOLOGIES INC A | $1.9m0.16% | Added +10.3k |
| INTUITIVE SURGICAL INC ISRG | $1.9m0.16% | New |
| HESKA CORP HSKA | $1.9m0.15% | Reduced -65.1k |
| EXAGEN INC XGN | $1.8m0.15% | Added +22.8k |
| PROTHENA CORP PLC PRTA | $1.7m0.14% | Reduced -134.8k |
| KEROS THERAPEUTICS INC KROS | $1.7m0.14% | New |
| INTERSECT ENT INC XENT | $1.6m0.13% | New |
| TELIGENT INC NEW COM NEW | $1.6m0.13% | New |
| CONFORMIS INC CFMS | $1.5m0.13% | New |
| LIQUIDIA CORPORATION LQDA | $1.3m0.11% | New |
| IQVIA HLDGS INC IQV | $1.1m0.09% | Added +1.8k |
| CHEWY INC CHWY | $1.1m0.09% | New |
| RITE AID CORP RAD | $1.1m0.09% | Reduced -478.0k |
| INFLARX NV IFRX | $1.0m0.09% | New |
| CABALETTA BIO INC CABA | $853.0k0.07% | New |
| GOHEALTH INC COM CL A | $805.4k0.07% | Added +39.2k |
| IMMUTEP LTD SPONSORED ADS | $767.2k0.06% | New |
| APELLIS PHARMACEUTICALS INC APLS | $553.5k0.05% | Added +9.1k |
| QUIDEL CORP QDEL | $528.6k0.04% | Reduced -36.5k |
| APTOSE BIOSCIENCES INC COM NEW | $478.0k0.04% | New |
| REPLIGEN CORP RGEN | $277.6k0.02% | New |
Sold out since Q4 2020
| Security | Value then |
|---|---|
| SAREPTA THERAPEUTICS INC SRPT | $23.6m138.6k shares |
| AURINIA PHARMACEUTICALS INC AUPH | $8.4m604.4k shares |
| OXFORD IMMUNOTEC GLOBAL PLC OXFD | $5.4m307.7k shares |
| ALTIMMUNE INC ALT | $4.3m380.0k shares |
| BIOCRYST PHARMACEUTICALS INC BCRX | $3.7m491.9k shares |
| SANOFI SNY | $3.3m68.1k shares |
| SESEN BIO INC | $2.1m1.6m shares |
| ANAPTYSBIO INC ANAB | $1.9m88.3k shares |
| ONCTERNAL THERAPEUTICS INC GTXI | $1.7m344.1k shares |
| OTONOMY INC OTIC | $1.6m253.3k shares |
| AUTOLUS THERAPEUTICS PLC AUTL | $1.4m155.0k shares |
| CONCERT PHARMACEUTICALS INC CNCE | $1.3m103.8k shares |
| CATABASIS PHARMACEUTICALS IN CATB | $1.1m522.0k shares |
| PROTARA THERAPEUTICS INC TARA | $879.1k36.3k shares |
| KALVISTA PHARMACEUTICALS INC KALV | $359.4k18.9k shares |
| ZYMEWORKS INC ZYME | $255.4k5.4k shares |
| MERUS N V MRUS | $253.2k14.4k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| GLAXOSMITHKLINE PLC Call | $41.2m1.2m shares | Added |
| SPDR S&P 500 ETF TR SPY · Put | $39.6m100.0k shares | New |
| VERTEX PHARMACEUTICALS INC VRTX · Call | $12.9m60.0k shares | New |
| ARK ETF TR ARKG · Put | $5.0m56.9k shares | New |
| CENTENE CORP DEL CNC · Call | $3.2m50.0k shares | New |
| AMARIN CORP PLC Call | $2.7m440.8k shares | Reduced |
| FREQUENCY THERAPEUTICS INC Put | $1.8m193.6k shares | New |
| NOVAVAX INC NVAX · Call | $1.8m10.0k shares | New |
| ACADIA PHARMACEUTICALS INC ACAD · Call | $645.0k25.0k shares | New |
| OTONOMY INC OTIC · Call | $505.9k198.4k shares | New |
| FREQUENCY THERAPEUTICS INC Call | $94.8k10.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |